Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision stamp was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:20:51.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Massachusetts and Washington listings; removed the HHS Vulnerability Disclosure link; updated page revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T20:50:41.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added as a minor site update and does not affect study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T00:30:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page, and the study details and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T20:07:33.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now includes posted results for NCT02919969, including primary and secondary outcomes, and updated study record dates.
    Difference
    0.5%
    Check dated 2025-11-03T14:25:06.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus a version bump to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T04:28:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.